» Articles » PMID: 8666916

Localization of the Binding Site for the Monocyte Immunoglobulin (Ig) A-Fc Receptor (CD89) to the Domain Boundary Between Calpha2 and Calpha3 in Human IgA1

Overview
Journal J Exp Med
Date 1996 Apr 1
PMID 8666916
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Immunoglobulin (Ig) A serves as the first line of humoral defense at all mucosal surfaces and is present in large quantities of blood. In playing its role in humoral immunity, IgA interacts with a variety of effector molecules present both in serum and on the surfaces of immune and inflammatory cells. To study these interactions, we previously established expression of human IgA1 in insect cells using recombinant baculoviruses and showed that the expressed antibody is a structurally and functionally intact polypeptide useful for examining the molecular properties of IgA. Indeed, since the C alpha 2 N-linked glycosylation site lies near the Fab-distal pole of C alpha 2, the inability of a mutant IgA1 lacking C alpha 2 N-glycosylation to bind its cognate receptor suggested that the monocyte Fc alpha receptor (mFcalphaR) recognizes IgA at a hinge-distal site encompassing the boundary between the C alpha 2 and C alpha 3 domains. In this report, we utilize both domain-swapped IgA/IgG and point-mutated IgA chimeras to verify the above hypothesis. Using an antigen-specific rosetting assay and a mFc alpha R-expressing cell line, we show that (a) C alpha 2 and C alpha 3 together are necessary and sufficient for binding; (b) neither the IgA hinge nor the tailpiece is necessary for binding; (c) mutations away from the interdomain boundary do not affect binding; and (d) mutations located near the three-dimensional boundary between C alpha 2 and C alpha 3 completely disrupt binding. Taken together, these results localize the mFc alpha R recognition site on IgA to the boundary region between the second and third constant domains--a site analogous to that recognized by Staphylococcus aureus protein A on IgG. The use of this hinge-distal site is, to date, unique among Fc receptors of the Ig superfamily.

Citing Articles

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA.

Cottignies-Calamarte A, Tudor D, Bomsel M Front Immunol. 2023; 14:1037033.

PMID: 36817447 PMC: 9933243. DOI: 10.3389/fimmu.2023.1037033.


Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases.

Bosch-Amate X, Iranzo P, Ivars M, Mascaro Galy J, Espana A Front Immunol. 2021; 12:740820.

PMID: 34567003 PMC: 8462461. DOI: 10.3389/fimmu.2021.740820.


Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents.

van Tetering G, Evers M, Chan C, Stip M, Leusen J Antibodies (Basel). 2020; 9(4).

PMID: 33333967 PMC: 7768499. DOI: 10.3390/antib9040070.


IgA: Structure, Function, and Developability.

de Sousa-Pereira P, Woof J Antibodies (Basel). 2019; 8(4).

PMID: 31817406 PMC: 6963396. DOI: 10.3390/antib8040057.


FcαRI binding at the IgA1 C2-C3 interface induces long-range conformational changes that are transmitted to the hinge region.

Posgai M, Tonddast-Navaei S, Jayasinghe M, Ibrahim G, Stan G, Herr A Proc Natl Acad Sci U S A. 2018; 115(38):E8882-E8891.

PMID: 30181292 PMC: 6156678. DOI: 10.1073/pnas.1807478115.


References
1.
Plaut A, Wright A . Immunoglobulin A-metallo-type specific prolyl endopeptidases. Methods Enzymol. 1995; 248:634-42. DOI: 10.1016/0076-6879(95)48040-4. View

2.
Burton D, Woof J . Human antibody effector function. Adv Immunol. 1992; 51:1-84. DOI: 10.1016/s0065-2776(08)60486-1. View

3.
Tuaillon N, Taylor L, Lonberg N, Tucker P, Capra J . Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts. Proc Natl Acad Sci U S A. 1993; 90(8):3720-4. PMC: 46373. DOI: 10.1073/pnas.90.8.3720. View

4.
Kawamura S, Ueda S . Immunoglobulin CH gene family in hominoids and its evolutionary history. Genomics. 1992; 13(1):194-200. DOI: 10.1016/0888-7543(92)90220-m. View

5.
Simister N, Mostov K . An Fc receptor structurally related to MHC class I antigens. Nature. 1989; 337(6203):184-7. DOI: 10.1038/337184a0. View